DOW JONES22,260.83+1208.30 5.74%
S&P 5002,626.05+137.40 5.52%
NASDAQ7,793.94+420.86 5.71%

H.C. Wainwright Maintains Buy on Arcturus Therapeutics, Raises Price Target to $24

H.C. Wainwright maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target from $18 to $24.

Benzinga · 03/12/2020 11:50

H.C. Wainwright maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target from $18 to $24.